药物开发 药物开发
Jesse C Wiley1, Gregory A Cary2, Laura M Heath1
1Sage Bionetworks, Seattle, WA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
这项研究引入了阿尔茨海默病 (AD) 生物子域,以完善TREAT-AD管道中的多原子数据分析,使复杂数据集能够更好地映射到疾病生物学中,以改善治疗开发.
科学领域:
- 生物信息学是一种生物信息学.
- 基因组学就是基因组学.
- 系统生物学 系统生物学
背景情况:
- 协调阿尔茨海默病 (AD) 研究的多原子数据集至关重要.
- 现在的TREAT-AD管道包括19个AD生物领域.
- 这些域进一步细化为特定的子域,以增强生物绘图.
研究的目的:
- 开发一种方法,以便更有意义地将大型多原子数据集映射到AD相关生物学上.
- 在已建立的AD领域中完善生物特异性.
- 促进AD治疗的综合分析和假设生成.
主要方法:
- 该TREAT-AD管道使用来自多原子数据的全基因组基因中心风险评分.
- 生物领域是由基因本体学 (GO) 术语定义的.
- 卡帕网络是由GO术语和与疾病相关的基因构建的,然后被分割成子域.
主要成果:
- 确定了115个与AD相关的生物子域的核心集合.
- 这些子域提供了更具体的对齐与AD-linked生物学.
- 例如,线粒体新陈代谢中的子域,如电子运输链和TCA循环.
结论:
- 开发的AD生物域和子域为多原子数据集成提供了一个平台.
- 这种方法支持对AD的数据驱动假设生成.
- 它的目的是加速开发新的治疗策略和阿尔茨海默病的药物标.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
